The Association between 25-Hydroxyvitamin D Concentration and Telomere Length in the Very-Old: The Newcastle 85+ Study
by
,
Sarah Hakeem
1,2,3, 
Nuno Mendonça
4,5,
Terry Aspray
6,7,
Andrew Kingston
1,
Carmen Martin-Ruiz
8,
Louise Robinson
1 and
Tom R. Hill
1,2,* 1
Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
2
Human Nutrition Research Centre, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
3
College of Nursing, Umm Al-Quraa University, Makkah P.O. Box 715, Saudi Arabia
4
EpiDoC Unit, CEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1150-082 Lisbon, Portugal
5
Comprehensive Health Research Centre (CHRC), NOVA Medical School, Universidade Nova de Lisboa, 1150-082 Lisbon, Portugal
6
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
7
Freeman Hospital, NHS, Newcastle upon Tyne NE7 7DN, UK
8
Bioscreening Core Facility, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE4 5 PL, UK
*
Author to whom correspondence should be addressed.
Nutrients 2021, 13(12), 4341; https://doi.org/10.3390/nu13124341
Submission received: 24 September 2021
/
Revised: 23 November 2021
/
Accepted: 26 November 2021
/
Published: 1 December 2021
(This article belongs to the Special Issue Nutrition during the Lifespan: Underpinning Innovation?)
Abstract
:(1) Introduction: vitamin D may maintain the telomere length, either directly or via the inflammation effect and/or modulating the rate of cell proliferation. Whilst results from cross-sectional studies investigating the association between 25(OH)D concentration and telomere length have been mixed, there is a dearth of data from prospective studies which have assessed these associations. This study aimed to examine the association between 25(OH)D concentration in plasma and telomere length in blood cells in very-old adults (≥85 years old) at baseline, 18 months and 36 months by controlling for related lifestyle factors. (2) Methodology: our prospective cohort study comprised 775 participants from the Newcastle 85+ Study who had 25(OH)D measurements at baseline. Plasma 25(OH)D was stratified as <25 nmol/L (low), 25–50 nmol/L (moderate) and >50 nmol/L (high). Peripheral blood mononuclear cell telomere length was measured by quantitative real-time polymerase chain reaction at baseline, 18 and 36 months from baseline. (3) Results: a positive significant association was found between 25(OH)D concentration and telomere length amongst very-old participants at baseline (95% CI = 12.0–110.3, B = 61.2 ± 5.0, p = 0.015). This association was negative at 18 months (95% CI = −59.9–−7.5, B = −33.7 ± 13.3, p = 0.012) but was non-significant at 36 months. (4) Conclusion: Circulating 25(OH)D concentration shows inconsistent relationships with telomere length over time in very-old (85+ year old) adults.
1. Introduction
Telomeres, the specific deoxyribonucleic acid (DNA) protein structures, are the cap at both ends of each chromosome. Telomeres play an essential role in protecting the genome against nucleolytic destruction, recombination, repair, and interchromosomal fusion [1]. Each DNA replication causes telomere shortening and at the point when telomeres reach a critical limit, the cell undergoes senescence and/or apoptosis [2]. The enzyme telomerase plays a key role in the maintenance of telomere length [3]. Age is a well-established factor associated with telomere shortening [3,4]. In humans, telomere length decreases at a rate of 24.8–27.7 base pairs per year [2]. While telomere attrition with age is linked to a variety of age-related diseases and their complications, telomere attrition with ageing has been documented in multiple investigations regardless of the existence of any age-related disorders [3]. These observations support the view that shortened telomeres may serve as a potential candidate biomarker of ageing [3]. Telomere length is also affected by a combination of factors, including sex, genetics and lifestyle [2]. On the other hand, it is purported that the cellular and tissue defects associated with telomere dysfunction are mediated in part by oxidative stress and chronic inflammation mechanisms [5]. Accelerated telomere shortening is associated with mortality and many age-associated diseases, such as cardiovascular diseases, type 2 diabetes mellitus (T2DM), Alzheimer’s disease [1], as well as immune and infectious diseases [6] (Figure 1).
Evidence from animal models as well as human studies have demonstrated that various nutrients (e.g., folate, niacin, vitamin C, magnesium, zinc and omega-3 fatty acids), bioactives (e.g., polyphenols) and whole foods (e.g., tea) may influence telomere length and telomere attrition through mechanisms related to cellular functions including DNA repair and chromosome maintenance, DNA methylation, inflammation, oxidative stress and telomerase activity I (For review see [7]). Vitamin D may influence telomere length through its biologically active hormone 1α,25 dihydroxyvitamin D3 (calcitriol) [8]. Calcitriol is a potent immunosuppressant and has strong anti-inflammatory and anti-proliferative properties mediated in part by its ability to reduce gene expression of inflammatory mediators interleukin- 2 and interferon gamma [7]. The anti-inflammatory and anti-proliferative properties of calcitriol may reduce cell turnover, thus potentially reducing their telomere length attrition [7].
Limited population studies have assessed the association between circulating 25(OH)D concentration [the most commonly used nutritional biomarker of vitamin D] and telomere length [4,8,9,10,11,12,13,14,15,16]. A recent study [9] demonstrated that only at insufficient concentrations of 25(OH)D (50–75 nmol/L), telomerase activity is associated with survival times in CHD patients (mean age 59.9 years old). The findings by Richards et al. [10] and Liu et al. [11] demonstrated a positive association between 25(OH)D concentration and leukocyte telomere length (LTL) in women. On the other hand, a cross-sectional study of 2483 men aged 40–75 years did not observe a positive association between vitamin D biomarkers (25(OH)D and 1,25(OH)2D) and LTL [12]. Liu et al. [13] also found no association between absolute 25(OH)D concentrations and long LTL, for the overall population or the subgroups in the study (men, women, black and white separately) although maintaining a 25(OH)D concentration ≥30 nmol/L was significantly associated with longer LTL in white participants only. Yet, Zhu et al. [14] showed an increase in telomerase activity in 19 overweight African-American women after 16 weeks of vitamin D supplementation.
These conflicting results may be attributed to the differences between gender, race and ages of study participants. For instance, the age range in one study was 48–93 years old (a mean age of 62.8 years old) [13], whereas Richards et al. [10] studied younger women aged 18–79 years old (a mean age of 49.4 years old). Besides, other studies failed to prove the association between 25(OH)D and telomere length in younger participants (mean age 31–39 years old [15] [16]). Generally, these studies included a wide age range of participants with limited number of either very-old adults or participants younger than 70 years old, or participants of only one sex, which limited the generalizability of the findings for those older than 80 years old. Therefore, this study aimed to use the large dataset on both sexes from the Newcastle 85+ Study to examine the association between 25(OH)D concentration and telomere length in very-old adults (>85 years old) [17] at baseline and after 18 and 36 months. We hypothesize that, by controlling related lifestyle factors, a concentration of 25(OH)D <25 nmol/L (used to define vitamin D deficiency) will be associated with shorter telomere length in very-old adults.
2. Materials and Methods
2.1. Population Sample
The participants were taken from the Newcastle 85+ Study, which included both community-dwelling and institutionalised older adults aged 85 years old at recruitment and living in Newcastle-upon-Tyne and North Tyneside. Commencing in 2006, the study recruited a birth-cohort of more than 1000 adults aged 85 years from North-East England to understand in great detail, the biological, clinical and social determinants of health as the cohort ages. The study seeks to provide extensive data on the relevance of various social, molecular and cellular indicators in contributing to health of very old people [18]. Health assessments, which comprised questionnaires, measurements, function tests and a fasting blood sample as well as general practice (GP) medical records from which to extract data on diagnosed diseases and prescribed medication, were available for the 851 participants. The current paper includes those Newcastle 85+ Study participants (N = 775) whose data on health assessment, general practice records and 25(OH)D concentrations were available [18].
2.2. Ethical Approval
The study conformed with requirements set in the Declaration of Helsinki. The Newcastle and North Tyneside Research Ethics Committee granted ethical approval, and the participants provided signed informed consent (research project reference number: 06/Q0905/2).
2.3. Circulating 25(OH)D Assay and Definition of Vitamin D Status
Following an overnight fast, 40mL of blood was drawn from the participants via the antecubital vein between 7:00 am and 10:30 am. The majority of whole blood samples (95%) were received at the laboratory for processing within 1 h of venepuncture. The total 25(OH)D concentration in serum was estimated by the DiaSorin radio-immunoassay (RIA) kit (DiaSorin Corporation, Stillwater, MN) as described previously [19]. Circulating 25(OH)D measurements were only available at baseline sampling [19].
2.4. Telomere Length
Telomere length of peripheral blood mononuclear cell (PBMCs) was measured as an abundance of telomeric template versus a single gene by quantitative real-time PCR. The intra-assay coefficient of variation was 2.7% while the inter-assay coefficient of variation was 5.1% [19]. Four internal control DNA samples were run within each plate to correct for plate–to-plate variation. The measurements were performed in quadruplicate. All PCRs were carried out on an Applied Biosystems 7900HT Fast Real Time PCR machine (Applied Biosystems, Foster City, CA, USA) with a 384-well plate capacity [19].
Aviv et al. 2006 [21] proposes guidance for epidemiological research on the minimum numbers of subjects required for a given age range to determine whether the extrapolated telomere attrition rate of two groups are significantly different. For longitudinal studies assessing telomere length in older adults (>60 years) over time, the sample size required in each test group being compared for 80% power and p < 0.05 using a two sided t-test is 104 participants [21]. However, given the limited data on telomere attrition in those aged 85–88 years (the age range of the participants in this analysis), any power calculations for very old populations are purely speculative.
2.5. HbA1c Measurement
The glycosylated haemoglobin % (HbA1c) was measured using a Tosoh Eurogenetics automated HLC-723G7 HPLC analyser (Tosoh Bioscience, Tokyo, Japan) [19].
2.6. Other Health and Lifestyle Variables
2.6.1. Health and Morbidity
Information on health and morbidity was collected from GP medical records by a trained nurse. Diseases were recorded via a predetermined list of key diseases. All diagnoses of listed diseases were scored as present (score 1) or absent (score 0), together with the date of first diagnosis. A simple disease count was used (maximum score 18) from selected chronic diseases (See Supplementary Box S1). The participants were included only if all of the variables were scored as present or absent [18].
2.6.2. Lifestyle
The multidimensional health questionnaire included gender (men or women) and lifestyle factors (smoking, alcohol consumption and physical activity). Using data from the Newcastle 85+ pilot study, a physical activity questionnaire (PAQ) was developed and tested in this age range before being implemented. The participants were divided into three groups: low (scores 0–1), moderate (scores 2–6), and high (scores 7–18) on the PAQ. Physical activity levels are classified based on the frequency and intensity of physical activity performed each week (supplementary data Box S1, available in Age and Ageing online) [22]. For smoking, participants were categorized as non-smokers and occasional and regular smoker. In regard to alcohol consumption, participants were categorized as non-drinkers, moderate drinkers and heavy drinkers. Nutritional status was assessed by calculating body mass index (kg/m2) (BMI) from recorded height and weight and included in the models owing to its influence on telomere length [23].
Vitamin D supplement use was divided into two categories: no supplement users and supplement users. Because the only information available on supplement use was the brand and type, micronutrient-containing supplements were assumed to be taken according to the manufacturer’s instructions. The use of vitamin D supplements (yes/no) was collected via the interviewer-administered questionnaire, and prescriptions for vitamin D medicine were retrieved from GP records [24].
2.7. Statistical Analysis
The normality of the distributions was assessed by reviewing the histograms and Q-Q plots, and the Shapiro-Wilk test was applied. Normally-distributed, continuous variables are presented as means and standard deviations (SD), while non-Gaussian distributed variables are presented as medians and interquartile ranges (IQR). The categorical data are presented as percentages (with the corresponding sample size). Mann-Whitney and Kruskal-Wallis tests were used for ordered and non-normally distributed continuous variables, and a χ2 test for categorical variables.
The concentration of 25(OH)D was not normally distributed (and could not be normalized by transformation, as described previously [25]). In addition, telomere length was not normally distributed (and could not be normalized by transformation either). The 25(OH)D concentration was categorized by SACN cut-offs points for vitamin D [19]: <25 nmol/L (as low). In order to have equal participants distributed between the groups, we used 25–50 nmol/L (as moderate) (used as reference in the analysis) and >50 nmol/L (as high). To examine the association between 25(OH)D and telomere length at baseline, 18 months and 36 months, linear regression was used. The linearity and homoscedasticity assumptions were tested with residual normality versus predicted values plots. Important confounders were selected based on their clinical and theoretical relevance to the telomere length. These variables were then fitted, removed, and refitted until the best possible but parsimonious model was achieved while checking for model fit statistics throughout. Model 1 is an unadjusted model, Model 2 is adjusted for smoking and alcohol consumption, Model 3 is further adjusted for BMI and physical activity, and Model 4 is further adjusted for HbA1c. The models were stratified by sex.
All analyses were performed using IBM’s SPSS Statistics software, version 24 (IBM, New York, NY, USA), and p < 0.05 was considered statistically significant.
3. Results
3.1. Participants’ Characteristics
By using the 3 cut-off of 25(OH)D concentration (low, moderate and high), there are significant differences between men and women, BMI categories, PA level, vitamin D containing medication and supplements usage, their general health rate, telomere length and HbA1c measurement (Table 1). The majority of the participants were women, have normal weight, moderately active, non-alcohol drinker, regular smokers and rate their health as good.
3.2. Predictors of Telomere Length
No significant association was found between telomere length and the relative confounders from the literature, such as smoking, alcohol consumption, PA, BMI, vitamin D containing medication usage, supplement, disease count and HbA1c% amongst all the participants. The only significant association was between telomere length and sex (95% CI = 0.000–0.001, p < 0.001). In addition, no significant association was found between telomere length and the confounders when the participants were stratified by sex, except for the BMI among the women (95% CI = 0.0034–0.044, p = 0.039).
Table 1.
Participant characteristics by circulating 25(OH)D cut-offs in the Newcastle 85+ Study at baseline.
Table 1.
Participant characteristics by circulating 25(OH)D cut-offs in the Newcastle 85+ Study at baseline.
| Low (n = 193) | Moderate (n = 302) | High (n = 283) | All (n = 778) | p | |
|---|---|---|---|---|---|
| Women % (n) | 64.4 (123) | 53.8 (162) | 65.7 (186) | 60.8 (471) | 0.007 |
| BMI | 0.015 | ||||
| Underweight % (n) | 22.2 (39) | 30.0 (86) | 35.5 (91) | 30.0 (216) | |
| Normal weight % (n) | 43.8 (77) | 46.0 (132) | 41.0 (105) | 43.7 (314) | |
| Overweight % (n) | 19.9 (35) | 14.6 (42) | 17.2 (44) | 16.8 (121) | |
| Obese % (n) | 14.2 (25) | 14.2 (25) | 6.3 (16) | 9.5 (68) | |
| PA | 0.001 | ||||
| Low % (n) | 28.6 (54) | 15.4 (46) | 24.8 (70) | 22.1 (170) | |
| Moderate % (n) | 48.1 (91) | 131 (44) | 38.3 (108) | 42.9 (330) | |
| High % (n) | 23.3 (44) | 40.6 (121) | 36.9 (104) | 35.0 (269) | |
| Alcohol drinkers | 0.056 | ||||
| Never % (n) | 42.9 (81) | 40.1 (120) | 40.7 (113) | 41.0 (314) | |
| Moderate % (n) | 30.2 (57) | 39.5 (118) | 41.0 (114) | 37.7 (289) | |
| Heavy % (n) | 11.6 (22) | 10.7 (32) | 9.4 (26) | 10.4 (80) | |
| Smoking | 0.447 | ||||
| Never % (n) | 36.6 (70) | 33.3 (100) | 36.2 (102) | 35.2 (272) | |
| Occasional % (n) | 4.2 (8) | 6.3 (19) | 4.6 (13) | 5.1 (40) | |
| Regular % (n) | 59.2 (113) | 60.3 (181) | 59.2 (167) | 59.6 (461) | |
| Vitamin D containing medication % (n) | 0.0 (1) | 6 (17) | 38 (108) | 16.5 (126) | <0.001 |
| Supplement users % (n) | 4.7 (9) | 16.9 (51) | 32.5 (92) | 19.5 (152) | <0.001 |
| Self-rated health | 0.006 | ||||
| Very good % (n) | 37.7 (72) | 40.5 (122) | 41.7 (118) | 40.3 (312) | |
| Good % (n) | 53.9 (103) | 56.1 (169) | 55.1 (156) | 55.2 (428) | |
| Poor % (n) | 6.3 (12) | 2.1 (6) | 2.1 (6) | 3.0 (23) | |
| Disease count mean (SD) | 4.9 (1.8) | 4.7 (1.6) | 4.8 (1.9) | 4.8 (1.8) | 0.675 |
| Telomere length sample % (n) | 0.678 | ||||
| At baseline | 44.7 (190) | 42.3 (291) | 42.3 (271) | 42.9 (752) | |
| At 18 months | 32.2 (137) | 32.6 (224) | 33.7 (216) | 32.9 (577) | |
| At 36 months | 23.0 (98) | 25.0 (172) | 23.9 (153) | 24.1 (423) | |
| Telomere length (kb) Median (IQR) | 0.006 | ||||
| At baseline | 3827.1 (1641) | 3721.0 (1094) | 4009.5 (1021) | 4034.6 (800.1) | |
| At 18 months | 3809.2 (236) | 3811.8 (542) | 3678.5 (487) | 3785.2 (415.5) | |
| At 36 months | 2702.1 (1184) | 2718.9 (1142) | 2781.3 (842) | 2832.7 (741.2) | |
| HbA1c (%) mean (SD) | 6.1 (1.1) | 6.0 (0.7) | 5.8 (0.6) | 5.9 (0.7) | 0.025 |
BMI: body mass index. HbA1c: glycated haemoglobin. Kb: kilo-base pair. p: p-value. Mann-Whitney U test for continuous non-normally distributed variables or χ2 test for categorical variables. 25(OH)D: <25 nmol/L (low), 25–50 nmol/L (moderate), >50 nmol/L (high).
3.3. Circulating 25(OH)D Concentration and Telomere Length among the Very-Old Adults at Baseline
A positive association was found between 25(OH)D and telomere length in very-old adults (See Figure 2 for the distribution of 25(OH)D concentrations by telomere length at baseline). Participants with 25(OH)D concentration >50 nmol/L had longer telomere length compared to those with concentration <50 nmol/L in the unadjusted model (95% CI = 17.8–109.9, B = 63.9 ± 23.4, p = 0.007), and even after adjusting for relevant confounders, such as smoking, alcohol consumption, BMI, physical activity and HbA1C (95% CI = 12.0–110.3, B = 61.29 ± 25.0, p = 0.015) (Table 2).
3.4. Circulating 25(OH)D Concentration and Telomere Length by Sex
Since sex was the only predictor of telomere length that was found for the current participants, the participants were stratified using this factor. When the participants were stratified by sex (Table 3), the very-old men with concentration between <25 nmol/L were more likely to have shorter telomere length compared to those with concentration 25–50 nmol/L in the unadjusted model (95% CI = 1.9–473.4, B = 237.7 ± 119.7, p = 0.048) and even after adjusting for relevant confounders (95% CI = 14.9–521.6, B = 268.3 ± 128.6, p = 0.038).
In contrast, the very-old women with 25(OH)D concentration >50 nmol/L were more likely to have longer telomere length compared to those with concentration 25–50 nmol/L in the unadjusted model (95% CI = 15.6–137.3, B = 76.4 ± 30.9, p = 0.014). This association continued after further adjustments were made for smoking, alcohol consumption, BMI, and physical activity (95% CI = 6.8–138.1, B = 72.4 ± 33.3, p = 0.030) but it disappeared after adjusting for HbA1c (95% CI = −0.7–131.1, B = 65.1 ± 33.5, p = 0.053).
3.5. Circulating 25(OH)D Concentration and Telomere Length among the Very-Old Adults at 18 Months
A negative significant association was found between 25(OH)D concentration and telomere length at 18 months (See Figure 3 for the distribution of 25(OH)D concentrations by telomere length at 18 months). Very-old participants with 25(OH)D concentration >50 nmol/L were more likely to have shorter telomere length compared to those with concentration 25–50 nmol/L in the unadjusted model (95% CI = −55.9–−5.8, B = −30.9 ± 12.7, p = 0.016), and after adjusting for relevant confounders, such as smoking, alcohol consumption, BMI, physical activity and HbA1C HbA1C (95% CI = −59.9–−7.5, B = −33.7 ± 13.3, p = 0.012) (Table 4).
3.6. Circulating 25(OH)D Concentration and Telomere Length by Sex at 18 Months
When the participants were stratified by sex (Table 5), a negative association was found between 25(OH)D and Telomere Length in the very-old men. Very-old men with concentration >50 nmol/L were more likely to have shorter telomere length compared to those with concentration <50 nmol/L in the unadjusted model (95% CI = −107.3–−25.5, B = −66.2 ± 20.8, p = 0.002) and even after adjusting for relevant confounders (95% CI = −107.0–−23.3, B = −65.2 ± 21.2, p = 0.002).
However, no significant association was found between 25(OH)D and telomere length in the very-old women at 18 months in both unadjusted and adjusted models (see Table 5).
3.7. Circulating 25(OH)D Concentration and Telomere Length among the Very-Old Adults at 36 Months
No significant association was found between 25(OH)D concentration and telomere length after 36 months in the unadjusted model, or even after adjusting for relevant confounder smoking, alcohol consumption, BMI, physical activity and HbA1C% in all participants and in men and women separately (see Figure 4 and Table 6 and Table 7)
4. Discussion
4.1. Main Findings
To our knowledge, this is the first study which has examined the prospective association between circulating 25(OH)D concentration and telomere length in very-old adults (≥85 years). Our results show that in fully adjusted models, whilst there was a significant positive association between 25(OH)D (>50 nmol/L) and telomere length at baseline, the direction of association was reversed after 18 months and absent at 36 months. However, it should be noted that the strength of the positive and negative associations between 25(OH)D concentration and telomere length at baseline and 18, respectively were weak [adjusted R square 0.004 at baseline and 0.020 at 18 months].
4.2. Evidence from Other Studies
Telomeres, the specific DNA protein structures, are found at both ends of each chromosome. Their function is to protect the genome from nucleolytic degradation, unnecessary recombination, repair, and interchromosomal fusion [1]. Each DNA replication causes telomere shortening, and when the telomere length reaches a critical limit, the cell undergoes senescence and/or apoptosis [2]. The rate attrition differs between individuals and tissues, and is influenced by multiple factors. Inflammation and oxidative stress are the key determinants of telomere length, and even though some of the factors that heighten oxidative stress and inflammation are genetic, others are environmental in nature, such as smoking, alcohol consumption, obesity and a sedentary lifestyle. Moreover, several dietary factors, such as high energy consumption and the intake of high sugar foods, are also highly associated with inflammation [4,26]. While these lifestyle habits may be difficult to change, vitamin D concentration was easily modifiable through nutritional supplementation or sunlight exposure. Taking all of this into account, we sought to explore and study the association between 25(OH)D concentration and telomere length.
Our findings were in agreement with previous findings from two large studies on women by Richards et al. [10] and Liu et al. [11] ] (n = 2160 and n = 4604 participants, respectively). Both studies found that a higher 25(OH)D concentration was associated with longer LTL [10,11]. Also, a recent study by Zarei et al. [8] found an interaction between vitamin D and telomerase with regards to their relationship with the survival among 404 CVD patients. On the other hand, the findings from a large community-dwelling study conducted by Liu and colleagues [13], failed to find any association between continuous 25(OH)D concentrations and longer LTL not only for their entire population (n = 1154) but also in the white (n = 503), black (n = 651), female (711), male (447) or race–sex subgroups. However, they found that concentrations of vitamin D ≥30 nmol/L were significantly associated with longer LTL in whites only [13].
In a prospective study of 59 African-American systemic lupus erythematosus patients and their counterpart control subjects shorter telomeres were seen among all subjects with a 25(OH)D concentration <50 nmol/L [16]. Interestingly, the patients who remained vitamin D deficient after three months of follow up (n = 29), tended to have shorter telomeres than those patients whose 25-hydroxyvitamin D levels were replete [16], suggestive of a protective role of 25(OH)D in maintaining telomere length. Moreover, a large community-dwelling study conducted by Mazidi and colleagues [7], examined the association between 25(OH)D concentration and telomere length across a broad age range (age: 18–80 years old). The participants were free of any history of diabetes, coronary heart disease, angina, myocardial infarction, stroke or congestive heart failure, in both men (n = 2319) and women (n = 2668) [7]. A positive association was demonstrated between 25(OH)D concentration and telomere length in the limited-adjusted models. Both studies highlighted the possible role of 25(OH)D concentration in the maintenance of telomere length [7,16].
Our study also demonstrated an association between 25(OH)D and telomere length in men, which is inconsistent with a cross-sectional study in white men (n = 2483), which failed to observe an association between any of the vitamin D biomarkers (25(OH)D and 1,25(OH)D) and LTL [12]. However, the participants in the study by Julin et al. [12] were younger than our participants (the mean age was 64.1 years old). Furthermore, they defined 25(OH)D concentration by four quartiles with higher cut-offs (<50 nmol/L was the lowest quartile) while the current study showed that a 25(OH)D concentration >50 nmol/L, was positively associated with telomere length at baseline.
Regarding the contribution of sex to the association between 25(OH)D concentration and telomere length, several biologically plausible explanations for a difference between men and women have been suggested, such as men, in general, having shorter telomeres than women [27]. In addition, estrogen can stimulate the production of telomerase and is a potent antioxidant and regulator of antioxidant genes [28]. Therefore, it should be noted that the differences in sex could contribute toward the association between vitamin D status and telomere length.
Regarding the negative association between 25(OH)D concentration and telomere length at 18 months, the plausible explanations could be that 25(OH)D concentration was only measured at baseline and not at follow up phases. Another explanation could be that concentration >50 nmol/L might not have protective effect on telomere length at very-old age. However, it should be considered that the model is not explaining much of the variation (Adj R2 considered very low). Besides, the 95% CIs were wide even when the relationship was positively significant at baseline indicates a less precise estimate of the relationship. That said, we could not ascertain the protective association of high concentration of 25(OH)D on telomere length in very-old adults in the current population.
There are several potential mechanisms that may explain the association between telomere length and 25(OH)D concentration. Generally, an activated form of vitamin D has autocrine and paracrine roles, including reducing telomere shortening through both anti-inflammatory and antiproliferative mechanisms. First, the active form of vitamin D decreases the mediators of systemic inflammation, such as interleukin-2 and tumor necrosis factor [9]. Furthermore, vitamin D receptor is expressed in the T and B lymphocytes, natural killer cells, and monocytes, which promote the down-regulation of cytokines and other proinflammatory factors. Thus, it follows that vitamin D would attenuate the rate of telomere length attrition [7,29]. In addition, the retinoid x receptor (which is found widely distributed in cells and tissues and acts as the major contributor to vitamin D dependent transcription) may attenuate the relationship between vitamin D and telomere length has other roles in the cell that are independent of the vitamin D pathway. Therefore, the association between one common variant and a long telomere length does not necessarily imply a link between 25(OH)D and telomere length [12].
4.3. Strengths and Limitations
The study has several strengths, including its unique design, as well as the fact that the analysis is concentrated on a broadly representative age category of 85 years old; and that the statistical assumptions were met. Another key strength is that the study was adjusted for major potential confounders associated with telomere length (e.g., BMI, physical activity, smoking). It should also be noted however, that the findings reported here should be interpreted with caution due to the following limitations: firstly, its epidemiological design restricts any inference about causal relationships. Secondly, we did not include wider dietary factors as covariates in our models as we had no a priori knowledge from our dataset that these factors could associate with telomere length. As a result, unmeasured or uncontrolled factors may confound the findings, raising the risk of Type I error. Adding more confounders to the fully adjusted model, on the other hand, may have resulted in non-significant (bias) results and decreased power to detect significant relationships. Third, despite having longitudinal telomere length data spanning 36 months, serum 25(OH)D data was only collected at baseline.
5. Conclusions
Among the very-old in the Newcastle 85+ cohort study, 25(OH)D concentration was positively associated with telomere length at baseline. However, given the wide 95% CI and the conflicting directions of the associations at 18 months inclined to say that high concentration of 25(OH)D (>50 nmol/L) did not show protective effect on telomere length in very-old adults. In conclusion, high 25(OH)D concentration is positively associated with telomere length but does not have protective effect over time.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/nu13124341/s1. Supplemental Box S1: List of diseases collected from GP medical records.
Author Contributions
S.H., T.R.H., T.A. and N.M. were responsible for conception and designed the manuscript; S.H. was responsible for statistical analyses; S.H. wrote the paper, and had primary responsibility for the final content of the manuscript; T.R.H., T.A., N.M., A.K., C.M.-R. and L.R. critically reviewed and revised the manuscript for scientific content, and approved the final version. All authors have read and agreed to the published version of the manuscript.
Funding
The Newcastle 85+ study was jointly funded by the Medical Research Council and Biotechnology and Biomedical Science Research Council (G0500997), now part of UK Research and Innovation (UKRI) in addition to the Newcastle Healthcare Charity. The following waves were funded by the Dunhill Medical Trust (R124/0509), Newcastle University, UK Medical Research Council and the British Heart Foundation. Overall, the project was supported by National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. This particular analysis (vitamin D and telomere length) received no additional external funding.
Institutional Review Board Statement
The study conformed with requirements set in the Declaration of Helsinki. The Newcastle and North Tyneside Research Ethics Committee granted ethical approval (research project reference number: 06/Q0905/2).
Informed Consent Statement
Informed consent was obtained from all participants involved in the study.
Data Availability Statement
Data from the Newcastle 85+ Study is available through a formal application process to the study team. For details please visit https://research.ncl.ac.uk/85plus/datarequests/.
Acknowledgments
We thank the operational support from the North of England Commissioning Support Unit and the local general practitioners in addition to the research, management and administrative teams and of course the study participants and their family for providing the data.
Conflicts of Interest
Competing interests S.H., N.M., T.A., A.K., C.M.-R., L.R. and T.R.H. have no conflicts of interest. The opinions expressed in this paper are those of the authors and do not necessarily reflect the views of the organizations they work with.
References
- Pusceddu, I.; Farrell, C.-J.L.; Di Pierro, A.M.; Jani, E.; Herrmann, W.; Herrmann, M. The role of telomeres and vitamin D in cellular aging and age-related diseases. Clin. Chem. Lab. Med. CCLM 2015, 53, 1661–1678. [Google Scholar] [CrossRef] [Green Version]
- Shammas, M.A. Telomeres, lifestyle, cancer, and aging. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 28–34. [Google Scholar] [CrossRef] [Green Version]
- Muzumdar, R.; Atzmon, G. Telomere length and aging. In Reviews on Selected Topics of Telomere Biology; InTech: London, UK, 2012. [Google Scholar]
- Beilfuss, J.; Camargo, C.A., Jr.; Kamycheva, E. Serum 25-Hydroxyvitamin D Has a Modest Positive Association with Leukocyte Telomere Length in Middle-Aged US Adults. J. Nutr. 2017, 147, 514–520. [Google Scholar] [CrossRef] [Green Version]
- Morgan, G. Telomerase regulation and the intimate relationship with ageing. Res. Rep. Biochem. 2013, 3, 71–78. [Google Scholar]
- Cawthon, R.M.; Smith, K.R.; O’Brien, E.; Sivatchenko, A.; Kerber, R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361, 393–395. [Google Scholar] [CrossRef]
- Paul, L. Diet, Nutrition and Telomere Length. J. Nutr. Biochem. 2011, 10, 855–901. [Google Scholar] [CrossRef] [PubMed]
- Mazidi, M.; Michos, E.D.; Banach, M. The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: The National Health and Nutrition Examination Survey. Arch. Med Sci. AMS 2017, 13, 61. [Google Scholar] [CrossRef] [Green Version]
- Zarei, M.; Najafi, M.; Movahedi, E.; Javanbakht, M.H.; Choi, Y.-H.; Yaseri, M.; Shirvani, A.; Sellke, F.W.; Stranges, S. The predictive role of circulating telomerase and vitamin D for long-term survival in patients undergoing coronary artery bypass grafting surgery (CABG). PLoS ONE 2020, 15, e0237477. [Google Scholar] [CrossRef]
- Richards, J.B.; Valdes, A.M.; Gardner, J.P.; Paximadas, D.; Kimura, M.; Nessa, A.; Lu, X.; Surdulescu, G.L.; Swaminathan, R.; Spector, T.D. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am. J. Clin. Nutr. 2007, 86, 1420–1425. [Google Scholar] [CrossRef]
- Liu, J.J.; Prescott, J.; Giovannucci, E.; Hankinson, S.E.; Rosner, B.; Han, J.; De Vivo, I. Plasma Vitamin D Biomarkers and Leukocyte Telomere Length. Am. J. Epidemiol. 2013, 177, 1411–1417. [Google Scholar] [CrossRef]
- Julin, B.; Shui, I.M.; Prescott, J.; Giovannucci, E.L.; De Vivo, I. Plasma vitamin D biomarkers and leukocyte telomere length in men. Eur. J. Nutr. 2017, 56, 501–508. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, J.J.; Cahoon, E.K.; Linet, M.S.; Little, M.P.; Dagnall, C.L.; Higson, H.; Savage, S.A.; Freedman, D.M. Relationship between plasma 25-hydroxymitamin D and leucocyte telomere length by sex and race in a US study. Br. J. Nutr. 2016, 116, 953–960. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhu, H.; Guo, D.; Li, K.; Pedersen-White, J.; Stallmann-Jorgensen, I.S.; Huang, Y.; Parikh, S.; Liu, K.; Dong, Y. Increased telomerase activity and vitamin D supplementation in overweight African Americans. Int. J. Obes. 2012, 36, 805–809. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Williams, D.M.; Palaniswamy, S.; Sebert, S.; Buxton, J.L.; Blakemore, A.I.F.; Hyppönen, E.; Jarvelin, M.-R. 25-Hydroxyvitamin D Concentration and Leukocyte Telomere Length in Young Adults: Findings From the Northern Finland Birth Cohort 1966. Am. J. Epidemiol. 2016, 183, 191–198. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hoffecker, B.M.; Raffield, L.M.; Kamen, D.L.; Nowling, T.K. Systemic lupus erythematosus and vitamin D deficiency are associated with shorter telomere length among African Americans: A case-control study. PLoS ONE 2013, 8, e63725. [Google Scholar] [CrossRef]
- Hill, T.R.; Mendonca, N.; Granic, A.; Siervo, M.; Jagger, C.; Seal, C.J.; Kerse, N.; Wham, C.; Adamson, A.J.; Mathers, J.C. What do we know about the nutritional status of the very old? Insights from three cohorts of advanced age from the UK and New Zealand. Proc. Nutr. Soc. 2016, 75, 420–430. [Google Scholar] [CrossRef] [Green Version]
- Collerton, J.; Davies, K.; Jagger, C.; Kingston, A.; Bond, J.; Eccles, M.P.; Robinson, L.A.; Martin-Ruiz, C.; von Zglinicki, T.; James, O.F.W.; et al. Health and disease in 85 year olds: Baseline findings from the Newcastle 85+ cohort study. BMJ 2009, 339, b4904. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martin-Ruiz, C.; Jagger, C.; Kingston, A.; Collerton, J.; Catt, M.; Davies, K.; Dunn, M.; Hilkens, C.; Keavney, B.; Pearce, S.H.S.; et al. Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study. Mech. Ageing Dev. 2011, 132, 496–502. [Google Scholar] [CrossRef]
- SACN (Scientific Advisory Committee on Nutrition). Vitamin D and Health. 2016. Available online: https://www.gov.uk/government/publications/sacn-vitamin-d-and-health-report (accessed on 5 July 2021).
- Aviv, A.; Valdes, A.M.; Spector, T.D. Human telomere biology: Pitfalls of moving from the laboratory to epidemiology. Int. J. Epidemiol. 2006, 35, 1424–1429. [Google Scholar] [CrossRef] [Green Version]
- Innerd, P.; Catt, M.; Collerton, J.; Davies, K.; Trenell, M.; Kirkwood, T.B.L.; Jagger, C. A comparison of subjective and objective measures of physical activity from the Newcastle 85+ study. Age Ageing 2015, 44, 691–694. [Google Scholar] [CrossRef] [Green Version]
- Gielen, M.; Hageman, G.J.; Antoniou, E.E.; Nordfjall, K.; Mangino, M.; Balasubramanyam, M.; de Meyer, T.; Hendricks, A.E.; Giltay, E.J.; Hunt, S.C.; et al. Body mass index is negatively associated with telomere length: A collaborative cross-sectional meta-analysis of 87 observational studies. Am. J. Clin. Nutr. 2018, 108, 453–475. [Google Scholar] [CrossRef]
- Mendonça, N.; Hill, T.; Granic, A.; Mathers, J.; Wrieden, W.; Siervo, M.; Seal, C.; Jagger, C.; Adamson, A. Micronutrient intake and food sources in the very old. Proc. Nutr. Soc. 2015, 74, E232. [Google Scholar] [CrossRef] [Green Version]
- Hill, T.; Granic, A.; Davies, K.; Collerton, J.; Martin-Ruiz, C.; Siervo, M.; Mathers, J.; Adamson, A.; Francis, R.; Pearce, S. Serum 25-hydroxyvitamin D concentration and its determinants in the very old: The Newcastle 85+ Study. Osteoporos. Int. 2016, 27, 1199–1208. [Google Scholar] [CrossRef] [PubMed]
- Cassidy, A.; De Vivo, I.; Liu, Y.; Han, J.; Prescott, J.; Hunter, D.J.; Rimm, E.B. Associations between diet, lifestyle factors, and telomere length in women. Am. J. Clin. Nutr. 2010, 91, 1273–1280. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barrett, E.L.; Richardson, D.S. Sex differences in telomeres and lifespan. Aging Cell 2011, 10, 913–921. [Google Scholar] [CrossRef] [PubMed]
- Aviv, A.; Valdes, A.; Gardner, J.P.; Swaminathan, R.; Kimura, M.; Spector, T.D. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J. Clin. Endocrinol. Metab. 2006, 91, 635–640. [Google Scholar] [CrossRef] [Green Version]
- Zarei, M.; Zarezadeh, M.; Kalajahi, F.H.; Javanbakht, M.H. The Relationship Between Vitamin D and Telomere/Telomerase: A Comprehensive Review. J. Frailty Aging 2020, 10, 2–9. [Google Scholar] [CrossRef] [PubMed]
Figure 1.
Schematic overview of the role of telomeres in tissue dysfunction and chronic disease.
Figure 2.
The association between 25(OH)D concentration and telomere length at baseline in the Newcastle 85+ Study.
Figure 2.
The association between 25(OH)D concentration and telomere length at baseline in the Newcastle 85+ Study.
Figure 3.
The association between 25(OH)D concentration and telomere length at 18 months in the Newcastle 85+ Study.
Figure 3.
The association between 25(OH)D concentration and telomere length at 18 months in the Newcastle 85+ Study.
Figure 4.
The association between 25(OH)D concentration and Telomere length at 36 months in the Newcastle 85+ Study.
Figure 4.
The association between 25(OH)D concentration and Telomere length at 36 months in the Newcastle 85+ Study.
Table 2.
Association between 25(OH)D cut-offs and telomere length at baseline.
| Model | 25(OH)D | β Coefficient | Adj. R Square | 95% CI | p |
|---|---|---|---|---|---|
| Model 1 | Low | 84.8 | 0.007 | −67.7, 237.5 | 0.275 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | 63.9 | 17.8, 109.9 | 0.007 | ||
| Model 2 | Low | 89.8 | 0.007 | −63.9, 243.6 | 0.252 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | 67.8 | 21.6, 114.1 | 0.004 | ||
| Model 3 | Low | 88.5 | 0.004 | −76.0, 253.2 | 0.291 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | 64.4 | 15.5, 113.2 | 0.010 | ||
| Model 4 | Low | 77.2 | 0.004 | −88.3, 242.8 | 0.360 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | 61.2 | 12.0, 110.3 | 0.015 |
CI: confidence interval. p: p-value. 25(OH)D cut-offs: <25 nmol/L (low), 25–50 nmol/L (moderate) (ref) and >50 nmol/L (high). Ref: reference group. BMI: body mass index. HbA1c: glycated haemoglobin. Model 1 is the unadjusted model. Model 2 is further adjusted for smoking and alcohol. Model 3 is further adjusted for BMI and physical activity. Model 4 is further adjusted for HbA1c%.
Table 3.
Association between 25(OH)D cut-offs and telomere length by sex at baseline.
| Sex | Model | 25(OH)D | β Coefficient | Adj. R Square | 95% CI | p |
|---|---|---|---|---|---|---|
| Men (n = 304) | Model 1 | Low | 237.7 | 0.009 | 1.9, 473.4 | 0.048 |
| Moderate | (ref) | (ref) | (ref) | |||
| High | 56.6 | −13.6, 126.9 | 0.114 | |||
| Model 2 | Low | 267.5 | 0.007 | 29.2, 505.7 | 0.028 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | 63.4 | −7.6, 134.6 | 0.080 | |||
| Model 3 | Low | 262.2 | 0.004 | 10.8, 513.5 | 0.041 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | 68.4 | −5.8, 142.7 | 0.071 | |||
| Model 4 | Low | 268.3 | 0.004 | 14.9, 521.6 | 0.038 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | 71.4 | −3.6, 146.4 | 0.062 | |||
| Women (n = 471) | Model 1 | Low | 28.8 | 0.011 | −172.1, 229.7 | 0.778 |
| Moderate | (ref) | (ref) | (ref) | |||
| High | 76.4 | 15.6, 137.3 | 0.014 | |||
| Model 2 | Low | 20.8 | 0.009 | −181.2, 223 | 0.839 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | 79.9 | 18.8, 141.0 | 0.010 | |||
| Model 3 | Low | −5.8 | 0.010 | −225.2, 213.6 | 0.958 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | 72.4 | 6.8, 138.1 | 0.030 | |||
| Model 4 | Low | −23.3 | 0.011 | −243.0, 196.3 | 0.835 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | 65.1 | −0.7, 131.1 | 0.053 |
CI: confidence interval. p: p-value. 25(OH)D cut-offs: <25 nmol/L (low), 25–50 nmol/L (moderate) (ref) and >50 nmol/L (high). Ref: reference group. BMI: body mass index. HbA1c: glycated haemoglobin. Model 1 is the unadjusted model. Model 2 is further adjusted for smoking and alcohol. Model 3 is further adjusted for BMI and physical activity. Model 4 is further adjusted for HbA1c%.
Table 4.
Association between 25(OH)D cut-offs and telomere length at 18 months.
| Model | 25(OH)D | β Coefficient | Adj. R Square | 95% CI | p |
|---|---|---|---|---|---|
| Model 1 | Low | −1.1 | 0.012 | −86.3, 84.1 | 0.979 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | −30.9 | −55.9, −5.8 | 0.016 | ||
| Model 2 | Low | −2.2 | 0.022 | −87.1, 82.7 | 0.959 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | −32.2 | −57.2, −7.3 | 0.011 | ||
| Model 3 | Low | −8.5 | 0.022 | −97.9, 80.8 | 0.851 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | −34.2 | −60.0, −8.3 | 0.010 | ||
| Model 4 | Low | −8.1 | 0.020 | −98.4, 82.0 | 0.859 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | −33.7 | −59.9, −7.5 | 0.012 |
CI: confidence interval. BMI: body mass index. HbA1c: glycated haemoglobin. p: p-value. 25(OH)D cut-offs: <25 nmol/L (low), 25–50 nmol/L (moderate) (ref) and >50 nmol/L (high). Model 1 is the unadjusted model. Model 2 is further adjusted for smoking and alcohol. Model 3 is further adjusted for BMI and physical activity. Model 4 is further adjusted for HbA1c%.
Table 5.
Association between 25(OH)D cut-offs and telomere length by sex at 18 months.
| Sex | Model | 25(OH)D | β Coefficient | Adj. R Square | 95% CI | p |
|---|---|---|---|---|---|---|
| Men (n = 304) | Model 1 | Low | −3.9 | 0.041 | −147.2, 139.3 | 0.957 |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −66.2 | −107.3, −25.5 | 0.002 | |||
| Model 2 | Low | −11.5 | 0.036 | −156.8, 133.6 | 0.875 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −69.0 | −110.4, −27.7 | 0.001 | |||
| Model 3 | Low | −16.7 | 0.037 | −167.8, 134 | 0.827 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −70.3 | −112.3, −28.3 | 0.001 | |||
| Model 4 | Low | −17.6 | 0.038 | −167.6, 132.4 | 0.817 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −65.2 | −107.0, −23.3 | 0.002 | |||
| Women (n = 471) | Model 1 | Low | 33.3 | −0.004 | −73.2, 139.8 | 0.539 |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −2.3 | −34.0, 29.3 | 0.883 | |||
| Model 2 | Low | 38.2 | 0.011 | −67.4, 143.8 | 0.477 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −2.8 | −34.4, 28.6 | 0.857 | |||
| Model 3 | Low | 21.8 | 0.004 | −90.9, 134.6 | 0.704 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −4.9 | −38.2, 28.3 | 0.770 | |||
| Model 4 | Low | 24.7 | 0.001 | −90.2, 139.6 | 0.672 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −6.5 | −40.6, 27.5 | 0.707 |
CI: confidence interval. BMI: body mass index. HbA1c: glycated haemoglobin. p: p-value. 25(OH)D cut-offs: <25 nmol/L, 25–50 nmol/L (moderate) (ref) and >50 nmol/L (high). Model 1 is the unadjusted model. Model 2 is further adjusted for smoking and alcohol. Model 3 is further adjusted for BMI and physical activity. Model 4 is further adjusted for HbA1c%.
Table 6.
Association between different 25(OH)D cut-offs and Telomere length at 36 months.
| Model | 25(OH)D | β Coefficient | Adj. R Square | 95% CI | p |
|---|---|---|---|---|---|
| Model 1 | Low | −12.6 | −0.002 | −205.4–180.2 | 0.898 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | −28.6 | -85.3–28.1 | 0.322 | ||
| Model 2 | Low | −18.4 | −0.007 | −213.3–176.4 | 0.853 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | −29.6 | −86.8–27.6 | 0.310 | ||
| Model 3 | Low | −5.7 | −0.003 | −209.5–198.1 | 0.956 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | −38.1 | −96.5–20.1 | 0.199 | ||
| Model 4 | Low | 16.2 | −0.004 | −189.8–222.3 | 0.877 |
| Moderate | (ref) | (ref) | (ref) | ||
| High | −36.8 | −96.3–22.6 | 0.225 |
CI: confidence interval. BMI: body mass index. HbA1c: glycated haemoglobin. p: p-value. 25(OH)D cut-offs: <25 nmol/L (low), 25–50 nmol/L (moderate) (ref) and >50 nmol/L (high). Model 1 is the unadjusted model. Model 2 is further adjusted for smoking and alcohol. Model 3 is further adjusted for BMI and physical activity. Model 4 is further adjusted for HbA1c.
Table 7.
Association between different 25(OH)D cut-offs and Telomere length by sex at 36 months.
| Sex | Model | 25(OH)D | B Coefficient | Adj. R Square | 95% CI | p |
|---|---|---|---|---|---|---|
| Men (n = 304) | Model 1 | Low | 12.7 | −0.013 | −295.0–320.5 | 0.935 |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −1.1 | −89.7–87.4 | 0.980 | |||
| Model 2 | Low | −2.1 | −0.025 | −315.1–310.8 | 0.989 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −4.7 | −94.5–84.9 | 0.916 | |||
| Model 3 | Low | −10.9 | −0.018 | −33.9–317.1 | 0.948 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −11.9 | −103.3–79.4 | 0.797 | |||
| Model 4 | Low | −12.1 | −0.015 | −103.3–82.7 | 0.827 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −10.2 | −173.3–89.5 | 0.530 | |||
| Women (n = 471) | Model 1 | Low | −34.0 | −0.002 | −286.9–218.9 | 0.791 |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −45.1 | −120.1–29.8 | 0.237 | |||
| Model 2 | Low | −33.5 | −0.010 | −288.1–221.0 | 0.795 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −44.5 | −120.2–31.0 | 0.247 | |||
| Model 3 | Low | −32.3 | −0.009 | −300.0–235.4 | 0.812 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −53.3 | −131.0–24.2 | 0.177 | |||
| Model 4 | Low | −0.8 | −0.008 | −271.3–269.6 | 0.995 | |
| Moderate | (ref) | (ref) | (ref) | |||
| High | −50.5 | −129.8–28.8 | 0.211 |
CI: confidence interval. BMI: body mass index. HbA1c: glycated haemoglobin. p: p-value. 25(OH)D cut-offs: <25 nmol/L (low), 25–50 nmol/L (moderate) (ref) and >50 nmol/L (high). Model 1 is the unadjusted model. Model 2 is further adjusted for smoking and alcohol. Model 3 is further adjusted for BMI and physical activity. Model 4 is further adjusted for HbA1c.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Hakeem, S.; Mendonça, N.; Aspray, T.; Kingston, A.; Martin-Ruiz, C.; Robinson, L.; Hill, T.R. The Association between 25-Hydroxyvitamin D Concentration and Telomere Length in the Very-Old: The Newcastle 85+ Study. Nutrients 2021, 13, 4341. https://doi.org/10.3390/nu13124341
AMA Style
Hakeem S, Mendonça N, Aspray T, Kingston A, Martin-Ruiz C, Robinson L, Hill TR. The Association between 25-Hydroxyvitamin D Concentration and Telomere Length in the Very-Old: The Newcastle 85+ Study. Nutrients. 2021; 13(12):4341. https://doi.org/10.3390/nu13124341
Chicago/Turabian StyleHakeem, Sarah, Nuno Mendonça, Terry Aspray, Andrew Kingston, Carmen Martin-Ruiz, Louise Robinson, and Tom R. Hill. 2021. "The Association between 25-Hydroxyvitamin D Concentration and Telomere Length in the Very-Old: The Newcastle 85+ Study" Nutrients 13, no. 12: 4341. https://doi.org/10.3390/nu13124341
APA StyleHakeem, S., Mendonça, N., Aspray, T., Kingston, A., Martin-Ruiz, C., Robinson, L., & Hill, T. R. (2021). The Association between 25-Hydroxyvitamin D Concentration and Telomere Length in the Very-Old: The Newcastle 85+ Study. Nutrients, 13(12), 4341. https://doi.org/10.3390/nu13124341
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
